体试验中的乙型肝炎捕捉功能治愈,指示机械途径,并建议预后生物标志物签名
Javiera Cortés-Ríos1, Tianjing Ren1, Nathan Hanan2
1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, USA.
Clinical pharmacology and therapeutics
|May 30, 2025
概括
慢性乙型肝炎的in silico试验通过模拟患者对治疗的反应来加速药物开发. 这种虚拟方法准确地预测功能治愈,并确定治疗成功的关键生物标志物.
科学领域:
- 计算生物学是一种计算生物学.
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 慢性乙型肝炎 (CHB) 治疗需要更好的药物开发预测模型.
- 目前的临床试验是漫长而昂贵的,需要创新的方法.
研究的目的:
- 开发和验证使用机械数学模型为CHB开发虚拟试验框架.
- 模拟临床方案和患者特征,以预测治疗结果.
主要方法:
- 为CHB.开发了一种机械学数学模型.
- 模拟的临床试验使用标准治疗方法 (核胺类型,基化干扰素).
- 在合成病毒学生物标志物数据集上利用机器学习来预测功能治愈.
主要成果:
- 该模型准确地模拟了功能治疗和复杂的临床观察.
- 鉴定了增强的细胞毒性免疫力和血清-氨酸转氨酶增加作为潜在的反应生物标志物.
- 较高的基线B型肝炎表面抗原与由于免疫上限导致的较低的治疗反应相关.
结论:
- 在 silico 试验可以加速 CHB 药物开发,并产生机械学假设.
- 虚拟患者和机器学习可以高准确度 (~95%) 预测功能治愈.
- 识别的生物标志物签名可能有助于预测CHB治疗结果.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...